Open AccessPhase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)
Author(s) -
Nguyen H. Tran,
Nathan R. Foster,
Amit Mahipal,
Thomas Byrne,
Joleen M. Hubbard,
Alvin Silva,
Kabir Mody,
Steven R. Alberts,
Mitesh J. Borad
Publication year - 2021
Publication title -
investigational new drugs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 87
eISSN - 1573-0646
pISSN - 0167-6997
DOI - 10.1007/s10637-021-01090-w
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , nausea , rash , gastroenterology , adverse effect , mucositis , vomiting , renal cell carcinoma , pharmacology , toxicity
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom